Diabetes is the most expensive chronic illness in the U.S., with $1 of every $4 in healthcare costs going to care for diabetics. The National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) estimates that $237 billion is spent directly on diabetes-related medical costs every year, while another $90… Continue reading In Search Of A Cure: The Growing Number Of Diabetics Is Inspiring A New Generation Of Therapies

The post In Search Of A Cure: The Growing Number Of Diabetics Is Inspiring A New Generation Of Therapies appeared first on ValueWalk.

Over the last several years, the healthcare industry has been changing rapidly due to a confluence of factors. One major transition that picked up steam during the COVID-19 pandemic is the push from in-office or in-hospital care to remote patient monitoring. In fact, one estimate suggests the remote patient monitoring… Continue reading Why Remote Patient Monitoring Has Just Gotten A Major Push Forward And How It’s Changing Healthcare Forever

The post Why Remote Patient Monitoring Has Just Gotten A Major Push Forward And How It’s Changing Healthcare Forever appeared first on ValueWalk.

The risks of developing many neurodegenerative diseases, including Alzheimer’s disease and amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig’s disease, increase significantly with age. However, there have been very few significant technological advances in treating these devastating diseases over the last few decades. The Search For Effective Treatments… Continue reading Why Targeting Regulatory T Cells Looks Promising In Treating Neurodegenerative Diseases

The post Why Targeting Regulatory T Cells Looks Promising In Treating Neurodegenerative Diseases appeared first on ValueWalk.

When Silicon Valley Bank collapsed, it triggered a domino effect within the banking sector. Signature Bank’s collapse came next, and the banking woes even spread across the Atlantic, touching Credit Suisse and even potentially Deutsche Bank. However, the fears about some of those said to be facing potential issues like… Continue reading It May Be Time To Buy The Dip In These Banking Stocks

The post It May Be Time To Buy The Dip In These Banking Stocks appeared first on ValueWalk.

January 2023 has been a bumpy month for stocks, albeit a positive one based on the S&P 500’s nearly 4% year-to-date return and the small-cap Russell 2000’s nearly 7% gain over the same timeframe. These January gains, especially the Russell 2000’s outperformance, back up the long-running theory referred to as… Continue reading The 2023 January Effect Is Just A Piece Of The Broader Wintertime Rally In Small-Caps

The post The 2023 January Effect Is Just A Piece Of The Broader Wintertime Rally In Small-Caps appeared first on ValueWalk.

Adoption of on-chain options remains low, but one firm sees a bright future for the asset class. It was only over the last few years that equity options really took off among retail investors, but once they began to understand the concept of options, a growing number of retail investors dove in. Could the same thing happen in DeFi with on-chain options?

The post Will On-Chain Options Ever Take Off In DeFi? appeared first on ValueWalk.

Energy was the only sector that outperformed in 2022, gaining nearly 60% versus the S&P 500’s almost 20% plunge by the time the year ended. As a result, many investors might be wondering whether that strength will continue in 2023. At least for now, we’re seeing companies like EQT and… Continue reading Energy Still Looks Attractive In 2023, Especially With These Dividend Picks

The post Energy Still Looks Attractive In 2023, Especially With These Dividend Picks appeared first on ValueWalk.

As fears about a possible recession continue to swirl, investors are looking for places to put their money to protect it against a severe economic downturn. The consumer staples sector can be a source of protection at a time when there is virtually nowhere for investors to hide. While stocks… Continue reading Coca-Cola Or Pepsi? Why The Answer For Investors Is Both!

The post Coca-Cola Or Pepsi? Why The Answer For Investors Is Both! appeared first on ValueWalk.

This year has been a rocky one for the crypto markets amid plummeting prices and a growing list of high-profile collapses by crypto firms. However, a closer look at what's going on reveals that it's the centralized firms that are buckling, leaving the DeFi firms unscathed. Here's how to tell the difference between a DeFi and CeFi crypto firm.

The post How To Spot The Differences Between DeFi And CeFi – And Why Crypto CeFi Is Collapsing appeared first on ValueWalk.

The energy sector has seen massive outperformance this year amid soaring oil and natural gas prices. However, many energy stocks have stabilized, presenting the question of whether there’s any more upside left and, if so, how much. What’s On Tap For Energy In 2023? Experts are starting to disagree about… Continue reading Why It’s Not Time To Give Up On Energy Stocks Yet, Despite What The Consensus Says

The post Why It’s Not Time To Give Up On Energy Stocks Yet, Despite What The Consensus Says appeared first on ValueWalk.